No Benefit of Additional Tumour Testing in HER2-negative Metastatic Breast Cancer with Already Confirmed Germline BRCA Mutations
Findings from a prespecified exploratory analysis of the OlympiAD study
Oncology News
ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
1533 results
More Than 25 Additional Years Needed to Slow an Increasing Incidence of Oropharyngeal Cancer by Current HPV Vaccination Rate
During this period most of oropharyngeal cancers will be among older non vaccinated individuals
Experts Propose a Clinical Definition of Acquired Resistance to PD-(L)1 Blockade in Advanced NSCLC
An attempt to unify terminology for future reports and clinical studies in patients with advanced non-small cell lung cancer
Studying Molecular Subtypes of Peritoneal Metastases in Gastric Cancer
Use of purified tumour cells from ascites and their corresponding cell lines as the resource for genomic analyses
FDA Approves Zanubrutinib for Waldenström’s Macroglobulinemia
This novel, small molecule inhibitor of Bruton's tyrosine kinase, was investigated in ASPEN study that compared zanubrutinib and ibrutinib in patients with MYD88 L265P mutation
A Personalised Prediction Model Based on Clinical and Genomic Data Outperforms Established Prognostic Models in MDS
New prediction model can provide probability of survival and leukaemia transformation at diagnosis of myelodysplastic syndrome and throughout a patient's disease course
Surveillance and Early Cancer Detection are Associated with Improved Survival in Constitutional Mismatch Repair Deficiency Syndrome
Data from patients with confirmed syndrome registered in the International Replication Repair Deficiency Consortium
Inguinofemoral Radiotherapy Could Spare Patients with Vulvar Cancer and Sentinel Node Micrometastases the Morbidity of Lymphadenectomy
The results of the GROINSS-V-II study
FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma
It also approved the Oncomine Dx Target Test as a companion diagnostic device to aid in patient selection
Impact of Multigene Germline Genetic Testing on Selection of Germline-Directed Therapy in Patients with Metastatic or Recurrent Cancer
Findings from an assessment of the utility of broad germline panel testing in a prospective pan-cancer cohort
Ability of Deep Learning to Accurately Diagnose Frequent STS Subtypes from Conventional Histopathological Slides
When aided by a deep learning model, pathologists make faster and more accurate diagnoses of soft tissue sarcomas
Molecular Determinantion of Outcomes in a Study with Pembrolizumab for Advanced Gastric/GEJ Cancer
Findings from a post hoc KEYNOTE-061 study analysis in second-line treatment for gastric/gastro-oesophageal junction adenocarcinoma